ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
34.93
+0.18 (0.53%)
Jul 1, 2026, 10:00 AM EDT - Market open

ArriVent BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,627854898---
Market Cap Growth
101.21%-4.88%----
Enterprise Value
1,292541.33679.26000
Last Close Price
34.9220.1226.64---
PB Ratio
4.862.783.49---
P/TBV Ratio
4.452.523.25---
Debt / Equity Ratio
0.0000.000.000.00-
Net Debt / Equity Ratio
-1.01-1.02-0.850.981.92-
Net Debt / EBITDA Ratio
2.081.762.322.014.42-
Net Debt / FCF Ratio
2.421.953.122.693.74-
Quick Ratio
13.0612.0612.6712.9419.54-
Current Ratio
13.9512.8313.1413.7621.84-
Return on Equity (ROE)
-46.02%-58.88%-39.36%-64.18%-113.98%-
Return on Assets (ROA)
-45.97%-58.39%-43.06%-43.12%-40.37%-
Return on Invested Capital (ROIC)
-32014.90%-733.45%-366.99%-1028.90%-657.33%-
Return on Capital Employed (ROCE)
-49.68%-62.86%-46.10%-45.77%-42.31%-
Buyback Yield / Dilution
-22.48%-22.22%-1369.88%-67.64%50.71%-
Total Shareholder Return
-22.48%-22.22%-1369.88%-67.64%50.71%-
SEC Filings: 10-K · 10-Q